Hasil Pencarian - Dimitri Breems
- Menampilkan 1 - 8 hasil dari 8
-
1
S249: SELECTIVE JAK2/IRAK1/ACVR1 INHIBITOR PACRITINIB BEFORE REDUCED-INTENSITY CONDITIONING ALLOGENEIC STEM CELL TRANSPLANTATION IN MYELOFIBROSIS: FINAL ANALYSIS OF THE PHASE II HO... oleh Ruben Van Dijck, Ron VAN DER Holt, Ellen Meijer, Timothy Devos, Mette Hazenberg, Marjolein Van Der Poel, Dimitri Breems, Lien Deleu, Nicolaas Schaap, Peter André Willem Te Boekhorst
Diterbitkan 2023-08-01
Artikel -
2
P565: REAL-WORLD DATA AS SUPPLEMENTARY CONTROLS FOR THE PROSPECTIVE RANDOMIZED HOVON-103 TRIAL IN INTENSIVELY TREATED ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS oleh Sjoerd Hermans, Yvette van Norden, Erik van Werkhoven, Avinash Dinmohamed, Peter Huijgens, Gert Ossenkoppele, Gerwin Huls, Bob Löwenberg, Thomas Pabst, Dimitri Breems, Douwe Postmus, Francesco Pignatti, Jurjen Versluis, Jan Cornelissen
Diterbitkan 2023-08-01
Artikel -
3
Viral Evolution and Immunology of SARS-CoV-2 in a Persistent Infection after Treatment with Rituximab oleh Nathalie Van der Moeren, Philippe Selhorst, My Ha, Laura Heireman, Pieter-Jan Van Gaal, Dimitri Breems, Pieter Meysman, Kris Laukens, Walter Verstrepen, Natasja Van Gasse, Benson Ogunjimi, Kevin K. Arien, Reinout Naesens
Diterbitkan 2022-04-01
Artikel -
4
P1608: REAL-WORLD INSIGHTS ON THE MANAGEMENT OF IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA (ITTP) WITH CAPLACIZUMAB IN BELGIUM oleh Daan Dierickx, Thierry Connerotte, Julie Dallemagne, Ann De Becker, Ine Moors, Sylvia Snauwaert, Anne Sonet, Koen Theunissen, Dimitri Breems, Bernard De Prijck, Aurélie Jaspers, Catherine Lambert, Bert Heyrman, Joris Hautekiet, Sofie Lyna, Chantal Maertens, Vanessa Delrieu
Diterbitkan 2023-08-01
Artikel -
5
Bayesian interim analysis for prospective randomized studies: reanalysis of the acute myeloid leukemia HOVON 132 clinical trial oleh Niek G. van der Maas, Jurjen Versluis, Kazem Nasserinejad, Joost van Rosmalen, Thomas Pabst, Johan Maertens, Dimitri Breems, Markus Manz, Jacqueline Cloos, Gert J. Ossenkoppele, Yngvar Floisand, Patrycja Gradowska, Bob Löwenberg, Gerwin Huls, Douwe Postmus, Francesco Pignatti, Jan J. Cornelissen
Diterbitkan 2024-03-01
Artikel -
6
P432: VALIDATION OF LIMIT OF QUANTIFICATION APPROACH BASED FLOW CYTOMETRY FOR MEASURABLE RESIDUAL DISEASE ASSESSMENT IN ACUTE MYELOID LEUKEMIA IN THE HOVON-SAKK-132 TRIAL oleh Jesse Tettero, Raffaele Palmieri, Lok Lam Ngai, Costa Bachas, Valentina Arena, Dimitri Breems, Thomas Fischer, Bjorn Tore Gjertsen, Laimonas Griškevičius, Gunnar Juliusson, Johan Maertens, Markus Manz, Luca Maurillo, Thomas Pabst, Jakob Passweg, Alfonso Piciocchi, Kimmo Porkka, Bob Löwenberg, Adriano Venditti, Gert Ossenkoppele, Francesco Buccisano, Jacqueline Cloos
Diterbitkan 2023-08-01
Artikel -
7
P475: EMERGING LEUKEMIA ASSOCIATED IMMUNOPHENOTYPES (LAIPS) IN BONE MARROW OF ACUTE MYELOID LEUKEMIA PATIENTS AFTER INTENSIVE CHEMOTHERAPY. oleh Lok Lam Ngai, Diana Hanekamp, Angèle Kelder, Willemijn J. Scholten, Jannemieke Carbaat - Ham, Alexander N. Snel, Costa Bachas, Jesse Tettero, Vincent van der Velden, Jennichjen Slomp, Willemijn Hobo, Dimitri Breems, Thomas Fischer, Bjorn Tore Gjertsen, Laimonas Griškevičius, Gunnar Juliusson, Johan Maertens, Markus Manz, Thomas Pabst, Jakob Passweg, Kimmo Porkka, Peter Valk, Patrycja Gradowska, Bob Löwenberg, David de Leeuw, Arjan van de Loosdrecht, Gert Ossenkoppele, Jacqueline Cloos
Diterbitkan 2023-08-01
Artikel -
8
Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine oleh Jacobien R. Hilberink, Isabelle A. van Zeventer, Dana A. Chitu, Thomas Pabst, Saskia K. Klein, Georg Stussi, Laimonas Griskevicius, Peter J. M. Valk, Jacqueline Cloos, Arjan A. van de Loosdrecht, Dimitri Breems, Danielle van Lammeren-Venema, Rinske Boersma, Mojca Jongen-Lavrencic, Martin Fehr, Mels Hoogendoorn, Markus G. Manz, Maaike Söhne, Rien van Marwijk Kooy, Dries Deeren, Marjolein W. M. van der Poel, Marie Cecile Legdeur, Lidwine Tick, Yves Chalandon, Emanuele Ammatuna, Sabine Blum, Bob Löwenberg, Gert J. Ossenkoppele, Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON), Swiss Group for Clinical Cancer Research (SAKK), Gerwin Huls
Diterbitkan 2023-06-01
Artikel